| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/28/2011 | CN101311171B Compound with dual restraining activities to acetyl cholinesterase and butyryl cholinesterase and use thereof |
| 09/28/2011 | CN101300252B Novel cycloalkane carboxamides as factor Xa inhibitors |
| 09/28/2011 | CN101297956B Medicine for treating empyrosis and eczema and producing method thereof |
| 09/28/2011 | CN101277952B Isoxazole derivatives |
| 09/28/2011 | CN101244252B Chinese medicine label for eliminating ache and preparation thereof |
| 09/28/2011 | CN101229187B Simethicone emulsion and preparing method thereof |
| 09/28/2011 | CN101214299B Spray coating type empyrosis medicinal liquor and preparation thereof |
| 09/28/2011 | CN101185721B Paste medicine for treating acute periodontitis |
| 09/28/2011 | CN101181425B Chinese medicine externally used liniment |
| 09/28/2011 | CN101181250B Antimicrobial compounds |
| 09/28/2011 | CN101160303B 1-(2H)-isoquinolone derivative |
| 09/28/2011 | CN101087760B Crystalline aripiprazole solvates |
| 09/27/2011 | USRE42755 Honey based wound dressing |
| 09/27/2011 | US8026385 Creatine oral supplementation using creatine hydrochloride salt |
| 09/27/2011 | US8026382 Lipid raft, caveolin protein, and caveolar function modulation compounds and associated synthetic and therapeutic methods |
| 09/27/2011 | US8026371 Hydroxamates as therapeutic agents |
| 09/27/2011 | US8026370 Peroxisome proliferator antagonist; hyperlipemia agents; arteriosclerosis; antiischemic agents |
| 09/27/2011 | US8026368 Hydrazide compounds and thrombopoietin receptor activators |
| 09/27/2011 | US8026366 Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines |
| 09/27/2011 | US8026365 4,4-disubstituted piperidine derivatives |
| 09/27/2011 | US8026341 Transfection complexes |
| 09/27/2011 | US8026327 Water-in-oil emulsions with ethylene oxide groups, compositions, and methods |
| 09/27/2011 | US8026283 Exo-S-mecamylamine formulation and use in treatment |
| 09/27/2011 | US8026282 Phenoxyalkylcarboxylic acid derivatives in the treatment of irritable bowel syndrome |
| 09/27/2011 | US8026281 Treating metabolic syndrome with fenofibrate |
| 09/27/2011 | US8026280 For therapy of cancer, hematological disorders, e.g., hemoglobinopathies, and genetic related metabolic disorders, e.g., cystic fibrosis and adrenoleukodystrophy. |
| 09/27/2011 | US8026279 Crystalline form of γ-aminobutyric acid analog |
| 09/27/2011 | US8026277 Flavor composition or fragrance composition, product containing the flavor composition or fragrance composition, and novel ester compound |
| 09/27/2011 | US8026276 Parenteral CCI-779 formulations containing cosolvents, an antioxidant, and a surfactant |
| 09/27/2011 | US8026275 Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury |
| 09/27/2011 | US8026274 increasing recovery rate and permanence of lean body mass without incident of hirsutism |
| 09/27/2011 | US8026273 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient |
| 09/27/2011 | US8026272 Modified lysine-mimetic compounds |
| 09/27/2011 | US8026271 Formulations of indol-3-yl-2-oxoacetamide compounds |
| 09/27/2011 | US8026270 Benzo [F] isoindoles as EP4 receptor agonists |
| 09/27/2011 | US8026269 Isoindoline compounds and methods of making and using the same |
| 09/27/2011 | US8026268 Method for scavenging radicals with urocanic acid, derivatives and analogues |
| 09/27/2011 | US8026267 Non-pegylated liposomal doxorubicin triple combination therapy |
| 09/27/2011 | US8026266 Treatment of length dependent neuropathy |
| 09/27/2011 | US8026265 Heterocycle substituted ketone derivatives as histone deacetylase (HDAC) inhibitors |
| 09/27/2011 | US8026264 Triazole derivatives as inhibitors of 11-β hydroxysteroid dehydrogenase-1 |
| 09/27/2011 | US8026263 Methods for inhibiting neoproliferative changes in blood vessel walls |
| 09/27/2011 | US8026262 Chemical compounds |
| 09/27/2011 | US8026261 Fluorinated derivatives of deferiprone |
| 09/27/2011 | US8026260 Histone deacetylase inhibitors with aryl-pyrazolyl-motifs |
| 09/27/2011 | US8026259 e.g. {5-Chloro-2-[4-(2-oxo-2,3-dihydro-benzooxazol-7-yl)-piperidine-1-carbonyl]-1H-indol-7-yl}-acetonitrile; vasopressin receptors antagonist; antidepressant, anxiolytic agent; dysmenorrhea, hypertension, inappropriate secretion of vasopressin, liver cirrhosis, obsessive compulsive disorder |
| 09/27/2011 | US8026258 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 09/27/2011 | US8026257 Substituted heterocyclic ethers and their use in CNS disorders |
| 09/27/2011 | US8026256 Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor |
| 09/27/2011 | US8026255 Substituted piperidines as somatostatin receptor subtype 5 (SSTR5) antagonists |
| 09/27/2011 | US8026254 Therapeutic agents useful for treating pain |
| 09/27/2011 | US8026253 Quinoline inhibitors of HCV polymerase |
| 09/27/2011 | US8026252 Large substituent, non-phenolic opioids and methods of use thereof |
| 09/27/2011 | US8026251 5-methylamino-11-ethylidene-5,6,9,10-tetrahydro-7-methyl-5,9-methanocycloocta[b]pyridin-2(1H)-one; acetylcholine esterase iinhibitor; analgesic, cognition activator; migraines, functional or organic pain syndrome, autoimmune diseases; easy permeation through the blood-brain barrier, long duration |
| 09/27/2011 | US8026250 Compositions for delivering highly water soluble drugs |
| 09/27/2011 | US8026249 Deuterium-enriched topotecan |
| 09/27/2011 | US8026248 4-[[4-[(2,6-dichloro-phenyl)methyl]-6-[[2-(1-pyrrolidinyl)ethyl]amino]-2-pyrimidinyl]amino]benzonitrile; 4-[[4-[(2,4,6-trimethylphenyl)amino]-2-pyrimidinyl]amino]benzamide, N1-oxide combined with another retrovirus inhibitor; viricides; treatment of AIDS |
| 09/27/2011 | US8026247 Bicyclic amides as kinase inhibitors |
| 09/27/2011 | US8026246 Aurora kinase inhibitors for inhibiting mitotic progression |
| 09/27/2011 | US8026245 HIV replication inhibiting purine derivatives |
| 09/27/2011 | US8026244 Thioxanthine derivatives and their use as inhibitors of MPO |
| 09/27/2011 | US8026242 Cyclopropyl amines as modulators of the histamine H3 receptor |
| 09/27/2011 | US8026241 Vanilloid receptor ligands and their use in treatments |
| 09/27/2011 | US8026240 Octahydro-pyrrolo[3,4-b]pyrrole N-oxides |
| 09/27/2011 | US8026239 Cell differentiation inducer |
| 09/27/2011 | US8026238 Topical antifungal composition |
| 09/27/2011 | US8026237 Pyrrole derivatives as pharmaceutical agents |
| 09/27/2011 | US8026236 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives |
| 09/27/2011 | US8026235 Pyridyl benzoxazine derivatives, pharmaceutical composition comprising the same, and use thereof |
| 09/27/2011 | US8026234 Polo-like kinase inhibitors |
| 09/27/2011 | US8026233 P38 inhibitors and methods of use thereof |
| 09/27/2011 | US8026231 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof |
| 09/27/2011 | US8026230 Methods and compositions for treating cancer using proteasome inhibitors |
| 09/27/2011 | US8026229 Inhibiting tubulin polymerization; treating prostate and breast cancer |
| 09/27/2011 | US8026228 Estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy |
| 09/27/2011 | US8026227 For reducing, preventing, mitigating, and/or delaying the onset of, attenuating the severity of, and/or hastening the resolution of, chemotherapy-associated toxicities; nucleosides |
| 09/27/2011 | US8026226 Administering effective amounts of the highly refined cellulose for lowering values of risk factor measurements for such diseases as diabetes and arteriosclerotic cardiovascular disorder |
| 09/27/2011 | US8026223 Treating malignant tumors with high field strength electroporation of plasmids encoding IL-12 |
| 09/27/2011 | US8026222 Use of oligosaccharide compound or glycomimetic compound wherein a cyclohexane derivative is incorporated therein; treating inflammatory, vascular, and skin disorders such as diabetes, atherosclerosis, dermatitis, graft versus host disease, and lymphomas |
| 09/27/2011 | US8026221 Method, composition and kit for antigenic binding of norwalk-like viruses |
| 09/27/2011 | US8026220 C-linked glucuronide of N-(4-hydroxybenzyl) retinone, analogs thereof, and method of using the same to inhibit neoplastic cell growth |
| 09/27/2011 | US8026217 Compositions and methods for treating neural anoxia and spreading depression |
| 09/27/2011 | US8026214 Liquid, aqueous pharmaceutical compositions of factor VII polypeptides |
| 09/27/2011 | US8026212 Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretatgogues |
| 09/27/2011 | US8026209 Administering a diagnostic agent with a carrier conjugated to a targeting molecule that binds to a lipopolysaccharide-sensitive polypeptide, which is either up-regulated or down-regulated in ECs by exposure to LPS; delivery into the EC vascular barrier and/or across the EC vascular barrier |
| 09/27/2011 | US8026109 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 09/27/2011 | US8025911 Preventive and/or remedy for inflammatory bowel diseases |
| 09/27/2011 | US8025907 Cosmetic composition to accelerate repair of functional wrinkles |
| 09/27/2011 | US8025905 Hydrolytically cleaving a plurality of peptide bonds in an allergenic polypeptide, using enzymes to denature all allergens; treating asthma, allergic rhinitis and atopic eczema in both humans and animals |
| 09/27/2011 | US8025899 Solid pharmaceutical dosage form |
| 09/27/2011 | US8025898 Enhanced drug delivery in transdermal systems |
| 09/27/2011 | US8025897 Ibuprofen composition |
| 09/27/2011 | US8025893 Cyclopamine can be used for obtaining decrease of pigmentation of hyperpigmented skin areas |
| 09/27/2011 | US8025892 Cosmetic particulate gel carriers for topically applied active agents |
| 09/27/2011 | US8025887 Avirulent, immunogenic flavivirus chimeras |
| 09/27/2011 | US8025883 Antagonists and methods for inhibiting angiogenesis |
| 09/27/2011 | US8025868 Compositions comprising an ultraviolet radiation-absorbing polymer |
| 09/27/2011 | CA2676424C Taxane derivatives and processes for the preparation thereof |
| 09/27/2011 | CA2658462C Substituted pyridone compounds and methods of use |
| 09/27/2011 | CA2649753C Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines |